Insider Transactions

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Insider Transactions

Date Name Title Filing Type Shares Traded Price Range Total Held
Feb 18, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 119,579 -- 445,806
Feb 18, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 144,944 -- 144,944
Feb 18, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 340,618 -- 340,618
Feb 18, 2021
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 110,309 -- 418,526
Feb 18, 2021
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 133,708 -- 133,708
Feb 18, 2021
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 314,213 -- 314,213
Feb 18, 2021
Chief Legal Officer
Chief Legal Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 110,309 -- 354,807
Feb 18, 2021
Chief Legal Officer
Chief Legal Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 133,708 -- 113,708
Feb 18, 2021
Chief Legal Officer
Chief Legal Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 314,213 -- 314,213
Feb 18, 2021
EVP, COO & CCO
EVP, COO & CCO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 134,410 -- 464,668
Feb 18, 2021
EVP, COO & CCO
EVP, COO & CCO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 162,921 -- 162,921
Feb 18, 2021
EVP, COO & CCO
EVP, COO & CCO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 382,865 -- 382,865
Feb 18, 2021
Director, CEO & President
Director, CEO & President Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 278,090 -- 648,119
Feb 18, 2021
Director, CEO & President
Director, CEO & President Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 337,079 -- 337,079
Feb 18, 2021
Director, CEO & President
Director, CEO & President Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 792,135 -- 792,135
Feb 17, 2021
Director
Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 $3.61 125,967
Feb 10, 2021
Chief Legal Officer
Chief Legal Officer Form 4 Open market or private sale of non-derivative or derivative security 2,500 $3.93 244,498
Feb 10, 2021
Chief Legal Officer
Chief Legal Officer Form 4 Other acquisition or disposition -- -- 6,250
Feb 09, 2021
Chief Legal Officer
Chief Legal Officer Form 4 Open market or private sale of non-derivative or derivative security 1,977 $3.93 246,998
Jan 20, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Form 4 Open market or private sale of non-derivative or derivative security 1,944 $4.31 330,608
Jan 20, 2021
EVP & Chief Financial Officer
EVP & Chief Financial Officer Form 4 Other acquisition or disposition -- -- 11,840
Jan 20, 2021
EVP, COO & CCO
EVP, COO & CCO Form 4 Open market or private sale of non-derivative or derivative security 10,000 $4.31 330,258
Jan 20, 2021
EVP, COO & CCO
EVP, COO & CCO Form 4 Other acquisition or disposition -- -- 14,139
Jan 20, 2021
Director, CEO & President
Director, CEO & President Form 4 Open market or private sale of non-derivative or derivative security 3,889 $4.31 370,029
Jan 20, 2021
Director, CEO & President
Director, CEO & President Form 4 Other acquisition or disposition -- -- 1,538

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.